Related Experiment Video

Updated: Aug 11, 2026

Development of a Negative Selectable Marker for Entamoeba histolytica
06:05

Development of a Negative Selectable Marker for Entamoeba histolytica

Published on: December 12, 2010

Inhibition of encystation of Entamoeba invadens by wortmannin

A Makioka1, M Kumagai, H Ohtomo

  • 1Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan. makioka@jikei.ac.jp

Parasitology Research
|June 14, 2001
PubMed

Insights

Wortmannin, a phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor, significantly reduced Entamoeba invadens encystation and growth. The drug

Area of Science:

  • Cell Biology
  • Parasitology
  • Biochemistry

Background:

  • Entamoeba invadens undergoes encystation, a crucial process for its survival and transmission.
  • Phosphatidylinositol 3-kinase (PI 3-kinase) is a key signaling molecule involved in various cellular functions.
  • Understanding the molecular mechanisms regulating encystation is vital for developing control strategies.

Purpose of the Study:

  • To investigate the role of PI 3-kinase signaling in the encystation of Entamoeba invadens.
  • To determine the effect of wortmannin, a PI 3-kinase inhibitor, on E. invadens encystation and growth.

Main Methods:

  • Utilized an axenic encystation system in vitro.
  • Treated Entamoeba invadens strain IP-1 with varying concentrations of wortmannin.
  • Assessed the impact of wortmannin on trophozoite growth, encystation rates, and cyst maturation.

Main Results:

  • Wortmannin inhibited both encystation and growth of E. invadens in a dose-dependent manner.
  • Encystation was more resistant to wortmannin than growth, and the drug's effect was not immediately toxic to trophozoites.
  • Wortmannin treatment inhibited encystation even when applied after induction, and the effect was largely irreversible in encystation medium.

Conclusions:

  • PI 3-kinase signaling appears to play a significant role in the regulation of Entamoeba invadens encystation.
  • Wortmannin's inhibitory effect suggests PI 3-kinase is essential for key steps in the encystation pathway.
  • Further research into PI 3-kinase's specific functions during encystation is warranted.

More Related Videos

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection11:49

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

Published on: June 12, 2014

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion09:22

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

Published on: July 3, 2026

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...